371 related articles for article (PubMed ID: 26425858)
21. Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry.
Zurkova M; Kriegova E; Kolek V; Lostakova V; Sterclova M; Bartos V; Doubkova M; Binkova I; Svoboda M; Strenkova J; Janotova M; Plackova M; Lacina L; Rihak V; Petrik F; Lisa P; Bittenglova R; Tyl R; Ondrejka G; Suldova H; Lnenicka J; Psikalova J; Snizek T; Homolka J; Kralova R; Kervitzer J; Vasakova M; ;
Respir Res; 2019 Jan; 20(1):16. PubMed ID: 30665416
[TBL] [Abstract][Full Text] [Related]
22. Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park SW; Park MS
Respir Res; 2016 Oct; 17(1):131. PubMed ID: 27756398
[TBL] [Abstract][Full Text] [Related]
23. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis.
Richeldi L; Ryerson CJ; Lee JS; Wolters PJ; Koth LL; Ley B; Elicker BM; Jones KD; King TE; Ryu JH; Collard HR
Thorax; 2012 May; 67(5):407-11. PubMed ID: 22426899
[TBL] [Abstract][Full Text] [Related]
24. Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohort.
Marcoux V; Lok SD; Mondal P; Assayag D; Fisher JH; Shapera S; Morisset J; Manganas H; Fell CD; Hambly N; Cox PG; Kolb M; Gershon AS; To T; Sadatsafavi M; Khalil N; Wong AW; Wilcox PG; Ryerson CJ; Vu T; Johannson KA
Respirology; 2024 Jul; 29(7):596-604. PubMed ID: 38436522
[TBL] [Abstract][Full Text] [Related]
25. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
26. Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis.
Brown AW; Shlobin OA; Weir N; Albano MC; Ahmad S; Smith M; Leslie K; Nathan SD
Chest; 2012 Oct; 142(4):1005-1010. PubMed ID: 22797563
[TBL] [Abstract][Full Text] [Related]
27. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.
Yoon HY; Kim TH; Seo JB; Lee SM; Lim S; Lee HN; Kim N; Han M; Kim DS; Song JW
Respirology; 2019 Jan; 24(1):55-62. PubMed ID: 30136753
[TBL] [Abstract][Full Text] [Related]
28. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
Durheim MT; Collard HR; Roberts RS; Brown KK; Flaherty KR; King TE; Palmer SM; Raghu G; Snyder LD; Anstrom KJ; Martinez FJ;
Lancet Respir Med; 2015 May; 3(5):388-96. PubMed ID: 25890798
[TBL] [Abstract][Full Text] [Related]
29. Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
Song H; Sun D; Ban C; Liu Y; Zhu M; Ye Q; Yan W; Ren Y; Dai H
Med Sci Monit; 2019 Jun; 25():4193-4201. PubMed ID: 31166938
[TBL] [Abstract][Full Text] [Related]
30. A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Ley B; Ryerson CJ; Vittinghoff E; Ryu JH; Tomassetti S; Lee JS; Poletti V; Buccioli M; Elicker BM; Jones KD; King TE; Collard HR
Ann Intern Med; 2012 May; 156(10):684-91. PubMed ID: 22586007
[TBL] [Abstract][Full Text] [Related]
31. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.
Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
BMC Pulm Med; 2017 Jul; 17(1):104. PubMed ID: 28743305
[TBL] [Abstract][Full Text] [Related]
33. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures.
Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Nair A; Karwoski R; Walsh SL; Wells AU; Hansell DM
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27811068
[TBL] [Abstract][Full Text] [Related]
34. Fat-free mass index predicts survival in patients with idiopathic pulmonary fibrosis.
Nishiyama O; Yamazaki R; Sano H; Iwanaga T; Higashimoto Y; Kume H; Tohda Y
Respirology; 2017 Apr; 22(3):480-485. PubMed ID: 27868303
[TBL] [Abstract][Full Text] [Related]
35. Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Respirology; 2017 Oct; 22(7):1379-1385. PubMed ID: 28543987
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis.
Lee H; Kim SY; Park YS; Choi SM; Lee JH; Park J
Sci Rep; 2024 Apr; 14(1):8857. PubMed ID: 38632477
[TBL] [Abstract][Full Text] [Related]
37. Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis: A Multicenter Retrospective Cohort Study.
Zaman T; Moua T; Vittinghoff E; Ryu JH; Collard HR; Lee JS
Chest; 2020 Jul; 158(1):245-251. PubMed ID: 32084394
[TBL] [Abstract][Full Text] [Related]
38. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
Alhamad EH; Masood M; Shaik SA; Arafah M
Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
[TBL] [Abstract][Full Text] [Related]
39. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis.
Akagi T; Matsumoto T; Harada T; Tanaka M; Kuraki T; Fujita M; Watanabe K
Respir Med; 2009 Aug; 103(8):1209-15. PubMed ID: 19251407
[TBL] [Abstract][Full Text] [Related]
40. Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality.
Loeh B; Brylski LT; von der Beck D; Seeger W; Krauss E; Bonniaud P; Crestani B; Vancheri C; Wells AU; Markart P; Breithecker A; Guenther A
Chest; 2019 May; 155(5):972-981. PubMed ID: 30742809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
